AVOMission Produce Inc
- Next report
- Dec 17
- Thursday, in 35 days · time not announced yet
- EPS expected
- $0.33
- quarter ending Oct 31, 2026
- Last result
- −$0.10Missed
- vs $0.05 expected on Jun 4
- Stock move on it
- −7.76%
- two sessions around the report
- Price
- $11.55
- −2.61% today · $1.15B cap
Past and upcoming reports
2
| Dec 17, 2026 | Oct 31, 2026 | Time not announced yet | $0.33 | not yet | |
| Jun 4, 2026 | Apr 30, 2026 | Time not given | $0.05 | Missed−$0.10 | −7.76%2d |
Pre-earnings read
No pre-earnings read for this report
None for this company right now.
After the report
Jun 4, 2026 report
Mission Produce Q4 EPS misses estimates by 269.5%, shares dip slightly post-earnings
Mission Produce reported Q4 EPS of -$0.10 versus an estimate of $0.06, missing by 269.5%. The stock declined about 1% following the earnings release. Despite a buy-tilted analyst consensus with a $17.5 target, weak revenue and EPS growth trends persist, and valuation remains mixed with a rich trailing P/E but cheaper forward P/E. Investors should watch for signs of margin recovery or integration progress from the recent Calavo acquisition.
Reported against expected
Reported EPS was -$0.1017, missing the consensus estimate of $0.06 by 269.5%.
Guidance
No explicit guidance was provided in the payload. forward EPS growth is forecasted at +33.3%.
How the stock reacted
Shares declined approximately 1% on the day of the earnings report, reflecting investor disappointment.
What changed
Q4 EPS missed estimates by 269.5%, reported at -$0.10 versus $0.06 expected.
What the price now assumes
Stock declined about 1% post-earnings, reflecting disappointment amid weak growth and margin pressure.
What it means for the business
Downgrade bias. monitor integration progress and margin improvement as key triggers.
The next one to three months, as we saw it then
Better case25%
Successful integration of Calavo and margin recovery drive EPS turnaround and share price appreciation.
Base case50%
Gradual improvement in margins and stable revenue growth with modest share price recovery.
Worse case25%
Persistent margin pressure and declining sales lead to further earnings deterioration and share price weakness.
If you hold it
Hold unless next quarter EPS or margin metrics improve materially from current levels.
If you are watching
Consider adding if quarterly reports show margin expansion or revenue growth. avoid if EPS misses continue.
Scenario odds are a judgement, not measured.